Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients

Jarrett J. Failing, Yiyi Yan, Luis F. Porrata, Svetomir N. Markovic

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients'. Together they form a unique fingerprint.

Medicine & Life Sciences